Product Information
DICLOFENAC SOD EC 75 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.0619 per EA under NDC 00228255106. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 26, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228255106
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA074514FDA Approved
3/26/1996
TE Code
AB
On Market Since
3/26/1996
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC SOD EC 75 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0619 per EA |
|---|---|
| All-time high | $0.2497 (Dec 11, 2013) |
| All-time low | $0.0619 (Sep 23, 2026) |
| 52-week high | $0.0821 |
| 52-week low | $0.0619 |
| Median price | $0.1094 |
| Average price | $0.1254 |
| Largest weekly change | -26.5% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC SOD EC 75 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC SOD EC 75 MG TAB, manufactured by Actavis Pharma, Inc., is $0.0619 per EA (NDC 00228255106), effective Sep 30, 2026.
How has the price of DICLOFENAC SOD EC 75 MG TAB changed over time?
Over the history we have for it, the NADAC for DICLOFENAC SOD EC 75 MG TAB has declined 75.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICLOFENAC SOD EC 75 MG TAB?
Since Nov 28, 2013, the NADAC for DICLOFENAC SOD EC 75 MG TAB has ranged from a low of $0.0619 (Sep 23, 2026) to a high of $0.2497 (Dec 11, 2013), with a median of $0.1094 per EA.
Are there cheaper alternatives to DICLOFENAC SOD EC 75 MG TAB?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC SOD EC 75 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC SOD EC 75 MG TAB?
DICLOFENAC SOD EC 75 MG TAB (NDC 00228255106) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.